Monomer Bio
PrivateLast Round
Seed
Feb 2, 2024
Total Funding Raised
$5.6M
Company Overview
Monomer Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in February 2024.
Monomer Bio is a healthcare technology company that provides an integrated lab automation and analytics software platform built for cell biology workflows.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Workflow Automation, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monomer Bio Comparables
Compare Monomer Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthace | 78% | |
| Automata | 77% | |
| Scispot | 75% |
For institutional investors. Book with your work email.
Monomer Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Monomer Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeX Ventures | Seed |
| LifeX Ventures | Seed |
| Notley | Seed |
| Talis Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 135% MoM, reaching 2.8K.
- Apr 28, 2025
Added The Organoid Company, a biotechnology startup, as a customer.
For institutional investors. Book with your work email.
Monomer Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Monomer Bio's valuation, stock price, and market status.
Is Monomer Bio a public or private company?
Monomer Bio is a private company.
What is the current stock price of Monomer Bio?
Monomer Bio is a private company, so its shares have no public market price. Caplight tracks Monomer Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Monomer Bio worth (valuation)?
Valuation information for Monomer Bio is not publicly available.
Can I buy Monomer Bio stock?
Monomer Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Monomer Bio's last funding round?
Monomer Bio's most recent funding round was Seed on February 2, 2024.
Who are the main investors in Monomer Bio?
Key investors in Monomer Bio include Talis Capital.
Will Monomer Bio IPO soon?
No public IPO plans have been announced for Monomer Bio.
How can I track Monomer Bio secondary market activity?
Caplight tracks bids, offers, and trades in Monomer Bio's shares on secondary markets.